![Per Grufman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per Grufman
Algemeen Directeur bij BioCrucible Ltd.
Actieve functies van Per Grufman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Algemeen Directeur | 20-01-2023 | - |
Loopbaan van Per Grufman
Eerdere bekende functies van Per Grufman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Karolinska Institutet | Directeur/Bestuurslid | - | - |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Hoofd Techniek/Wetenschap/O&O | - | 27-11-2009 |
Corporate Officer/Principal | 27-11-2009 | - | |
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Hoofd Techniek/Wetenschap/O&O | - | 27-11-2009 |
Corporate Officer/Principal | 27-11-2009 | - |
Opleiding van Per Grufman
Karolinska Institutet | Doctorate Degree |
University of Stockholm | Graduate Degree |
Statistieken
Internationaal
Zweden | 5 |
Verenigd Koninkrijk | 3 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Health Technology |
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Per Grufman
- Ervaring